Back
First Trust NASDAQ Technology Dividend Index Fund Vs. Cidara Therapeutics, Inc. Industry Stock Comparison
Sell
35
TDIV
First Trust NASDAQ Technology Dividend Index Fund
Last Price:
$96.65
Seasonality Move:
1.23%
Buy
75
CDTX
Cidara Therapeutics, Inc.
Last Price:
$220.02
Seasonality Move:
9.28%
Sell
35
First Trust NASDAQ Technology Dividend Index Fund (TDIV)
is a Sell
Is First Trust NASDAQ Technology Dividend Index Fund a Buy, Sell or Hold?
-
The current First Trust NASDAQ Technology Dividend Index Fund [TDIV] share price is $96.83. The Score for TDIV is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
-
TDIV is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
75
Cidara Therapeutics, Inc. (CDTX)
is a Buy
Is Cidara Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Cidara Therapeutics, Inc. [CDTX] share price is $220.10. The Score for CDTX is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
-
CDTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
TDIV Stock Price Chart
What is First Trust NASDAQ Technology Dividend Index Fund's stock price today?
-
The First Trust NASDAQ Technology Dividend Index Fund share price today is $96.83The current trend is moderately bearish and TDIV is experiencing selling pressure, which indicates risk of future bearish movement.
CDTX Stock Price Chart
What is Cidara Therapeutics, Inc.'s stock price today?
-
The Cidara Therapeutics, Inc. share price today is $220.10The current trend is moderately bullish and CDTX is experiencing slight selling pressure.
TDIV Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.53 | Buy |
| Relative Strength Index (14 RSI): | 45.12 | Sell |
| Chaikin Money Flow: | -87217 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (94.6 - 99.78) | Sell |
| Bollinger Bands (100): | (92.55 - 100.05) | Buy |
CDTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 20.3 | Buy |
| Relative Strength Index (14 RSI): | 84.85 | Buy |
| Chaikin Money Flow: | -80058 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (159.96 - 243.16) | Buy |
| Bollinger Bands (100): | (52.17 - 169.49) | Buy |
TDIV Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 99.78 | Sell |
| 20-day SMA: | 97.16 | Sell |
| 50-day SMA: | 98.51 | Sell |
| 200-day SMA: | 88.22 | Buy |
| 8-day EMA: | 98.88 | Sell |
| 20-day EMA: | 98.32 | Sell |
| 50-day EMA: | 95.92 | Buy |
| 200-day EMA: | 60.26 | Buy |
CDTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 220.22 | Sell |
| 20-day SMA: | 219.81 | Buy |
| 50-day SMA: | 152.4 | Buy |
| 200-day SMA: | 69.82 | Buy |
| 8-day EMA: | 219.59 | Buy |
| 20-day EMA: | 205.67 | Buy |
| 50-day EMA: | 165.16 | Buy |
| 200-day EMA: | 89.39 | Buy |
First Trust NASDAQ Technology Dividend Index Fund Earnings Growth & TDIV Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Cidara Therapeutics, Inc. Earnings Growth & CDTX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.42 per share, a decrease next quarter of $0.00 per share, an increase this year of $14.86 per share, and an increase next year of $1.78 per share.
First Trust NASDAQ Technology Dividend Index Fund Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Cidara Therapeutics, Inc. Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||